CEC
Coimbra, 3000-548, Portugal
NCT Number: NCT02500862
Characterize potential biomarkers of sight-threatening eye diseases based on the information acquired in clinical practice at CEC, AIBILI
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Coimbra, 3000-548, Portugal
This is a registry study. Only patients followed under the clinical practice at AIBILI Clinical Trial Centre, and with a signed informed consent form will be included.
Based on the clinical information collected under the clinical practice, and based on patients' characteristics, scientific questions will be raised and data will be collected and analysed accordingly.
Any procedure performed under clinical practice that may allow for the characterization of the disease and/or for the identification of potential biomarkers will be collected and analysed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 years
Association for Innovation and Biomedical Research on Light and Image
Other
Characterization of Potential Biomarkers of Eye Disease and Vision Loss.
Acronym: EYE-MARKER
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02821767
Eye Disease, Eye Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT07401459
AI Agent, Eye Disease
Hong Kong, China
View Trial DetailsNCT00386906
Eye Disease, Eye Diseases
Houston, Texas, United States
View Trial DetailsNCT06822023
Anxiety Disorders, Cataract Surgery
View Trial Details